1 There are three different macrophage types, naïve (M0), antitumor (M1), and protumor (M2). M1 macrophages accumulate at the tumor and exert antitumor activity. Researchers have attempted to use them ...
SPP1+ Macrophages Identified as Key Drivers and Therapeutic Targets In Colorectal Cancer Progression
Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-related deaths worldwide.
Circadian rhythms are endogenous time-keeping mechanisms that regulate physiological processes in response to external ...
Early diagnosis is crucial in disease prevention and treatment. Many diseases can be identified not just through physical ...
5mon
News Medical on MSNStudy reveals how inflammatory immune cells enhance prostate cancer resistanceResearchers focused particularly on the role of M1 and M2 macrophages in the tumor microenvironment. Macrophages are immune ...
Dr. Ram Murali, VP of Research and Development stated, “KROS 401 is designed to reverse the M1 to M2 transition of macrophages in the tumor microenviroment. What this translates to is changing ...
8mon
News Medical on MSNA unifying marker streamlines macrophage research across age and sexThis means that macrophages do not simply switch between the canonical two states previously described; instead, they can ...
SPP1+ macrophages identified as key drivers and therapeutic targets in colorectal cancer progression
Interestingly, this study noted an increase in the proportion of M1 macrophages and a decrease in M2 macrophages in CRC, contradicting the M1/M2 polarization theory. Functional analyses suggests ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results